Research and Development Team

The Research and Development Team at ARTHEx Biotech focuses on innovating and optimizing AntagomiR oligonucleotide therapies for Myotonic Dystrophy. This multidisciplinary team collaborates to advance preclinical and clinical research, ensuring the efficacy and safety of new treatments while navigating regulatory pathways to bring breakthroughs from bench to bedside.